共 13 条
- [13] The Association Between Treatment (tx) Modifications Due to Adverse Events (AEs) and Overall Survival (OS) in Patients (pts) With Advanced Renal Cell Carcinoma (RCC) Treated With Sunitinib and Sorafenib: Results From a Multi-country Study in Europe [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S515 - S516